digiDEM Bavaria HIGHLIGHT_04: New Dementia Medications – Are the New Medications Affordable?

In the fourth edition of our new special newsletter SCHLAGLICHT – New Drugs for Dementia, Florian Weidinger, research associate at digiDEM Bayern, deals with the publication "The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer’s disease: an EADC-EC viewpoint" by the research team led by Professor Linus Jönsson from the Karolinska Institutet in Sweden. In the journal The Lancet…

digiDEM Bavaria Symposium at the 12th Alzheimer's Congress in Fürth/Bavaria

At the 12th Congress of the German Alzheimer Society in the Stadthalle of Fürth/Bavaria, digiDEM Bavaria was not only represented with its own booth but also with a scientific symposium led by Prof. Dr. med. Elmar Gräßel, head of the Center for Medical Research at the University Hospital Erlangen and project manager of digiDEM…

Address anxieties in a timely manner

Anxiety is very common in older adults and people with dementia. However, those who experience chronic or new-onset anxiety also have a higher risk of developing dementia. This connection is particularly strong in people under 70 years of age. Researchers from Australia discovered this. Do people…

When dementia leads to depression

Researchers from the USA and Sweden investigated the risk of developing severe depression after an Alzheimer's diagnosis. More than four million people from Sweden participated in the study. Their findings were published in April 2024 in the renowned journal Alzheimer's & Dementia. If, with...

Dementia risk „haze“

A new study by Chinese scientists underscores the importance of not smoking at a young age and during pregnancy. Those who started smoking in early adolescence also developed dementia earlier. Furthermore, the researchers were able to establish a link between smoking during pregnancy...

digiDEM Bavaria HIGHLIGHT_03: New Drugs for Dementia – Helpful Treatment Alternative or Sham?

In the third issue of our new special newsletter "SCHLAGLICHT – New Medications for Dementia," Dr. Nikolas Dietzel, a research associate at digiDEM Bayern, discusses the publication by scientists from Europe, the USA, and Australia, led by Professor Poul F. Høilund-Carlsen from Odense University Hospital in Denmark. In the article titled "Donanemab, another anti-Alzheimer’s…"

Ambulant Supported Living Communities for People with Dementia – Insights from Practice and Science

Most people in need of care long for a home that allows them the greatest possible freedom and independence. Shared living arrangements with outpatient care are another option for people with dementia who can no longer live independently at home. This is especially true when moving to a residential care facility is not desired. In …